Sotex
↗Moscow, Russia
PharmFirma Sotex is a leading Russian pharmaceutical manufacturer and the core production asset of the Protek Group, one of the largest healthcare holdings in Eastern Europe. Founded in 2000, Sotex operates a high-tech manufacturing facility in the Sergiyev Posad district of the Moscow region, which was one of the first in Russia to be designed from the ground up according to EU GMP standards. The company specializes in the full-cycle production of complex injectable solutions, including biotechnological drugs and biosimilars.
Sotex focuses on high-demand therapeutic areas such as neurology, oncology, rheumatology, and nephrology. It plays a critical role in Russia's import substitution strategy, developing and manufacturing domestic versions of vital medicines. The company maintains a robust portfolio of over 150 products and is consistently ranked among the top five domestic pharmaceutical manufacturers by clinical trial activity and market share in the hospital segment.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$150M-$250M
Founded:2000
Ownership:subsidiary
Status:operating
FUNDING
Investors:Protek Group
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Biosimilars, Injectables, mAbs
Active Trials:15
Trial Phases:Phase 1: 2 | Phase 2: 3 | Phase 3: 10
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Protek Group
Subsidiaries:Rafarma (Partner/Subsidiary under Protek)
Key Partnerships:Sanofi (Historical contract manufacturing), Bayer (Historical localization partner), Eurasian Academy of Good Practices
COMPETITION
Position:Leader
Competitors:Biocad, Pharmstandard, R-Pharm, Generium, Pharmasyntez
LEADERSHIP
Key Executives:
Vadim Romanovich Yatsuk - General Director
Vadim Yakunin - Chairman of the Board, Protek Group
LINKS
Website:sotex.ru
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Sotex. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.